Clare Kahn is listed as an executive officer on 4 SEC Form D filings by 1 issuer between Apr 2019 and Jul 2019: X-Vax Technology, Inc. (Jupiter, FL — biotechnology — 2019; $56.5M reported sold to 306 investors).
What this means One deal on file with the SEC, filed Jul 2019. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside Andreas Eggert (4 shared filings), Brian D. Finn (4 shared filings), Ian T. Clark (4 shared filings), Isaac Blech (4 shared filings), Matthew Stober (4 shared filings) and 7 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Clare. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 4 public filings for Clare Kahn and found 5 differences: Offering amount changed between filings; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.